The "SBF2 Gene CMT4B2 Genetic Test" is a specific diagnostic procedure aimed at detecting mutations in the SBF2 gene, which are responsible for Charcot-Marie-Tooth disease type 4B2 (CMT4B2). Charcot-Marie-Tooth disease is a group of inherited disorders that affect the peripheral nerves, leading to muscle weakness and atrophy, as well as sensory problems. The SBF2 gene plays a crucial role in the development and maintenance of myelin, the protective sheath surrounding nerve fibers. Mutations in this gene disrupt myelin integrity, impairing nerve function and leading to the symptoms associated with CMT4B2.
This genetic test is a vital tool for diagnosing CMT4B2, allowing for precise genetic counseling and aiding in the development of targeted treatment plans for affected individuals. The test involves collecting a DNA sample, typically through a blood draw, which is then analyzed in a laboratory setting to identify mutations in the SBF2 gene.
The cost of the "SBF2 Gene CMT4B2 Genetic Test" is 4400 AED. It is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experienced professionals, ensuring accurate and reliable test results. This test is an important resource for individuals with a family history of Charcot-Marie-Tooth disease, offering them crucial information about their genetic health and helping guide their healthcare decisions.
The SH3TC2 gene CMT4C genetic test is a specialized diagnostic tool used to detect mutations in the SH3TC2 gene, which are associated with Charcot-Marie-Tooth disease type 4C (CMT4C). CMT4C is a rare form of Charcot-Marie-Tooth disease, a group of disorders that affect the peripheral nerves, leading to muscle weakness and sensory problems primarily in the arms and legs. The test is crucial for confirming the diagnosis, understanding the disease progression, and making informed decisions about management and treatment options.
Performed at DNA Labs UAE, this genetic test involves collecting a DNA sample, usually through a blood draw or a cheek swab, and analyzing the SH3TC2 gene for specific mutations. The accuracy and reliability of the test make it a valuable resource for affected individuals and their families.
The cost of the SH3TC2 gene CMT4C genetic test at DNA Labs UAE is 4400 AED. This investment can provide essential information for the clinical management of patients with or at risk of developing CMT4C, enabling early intervention and personalized care plans to improve quality of life.
The NDRG1 Gene CMT4D Genetic Test is a specialized diagnostic procedure aimed at detecting mutations in the NDRG1 gene, which are linked to Charcot-Marie-Tooth disease type 4D (CMT4D). CMT4D is a rare form of hereditary motor and sensory neuropathy, characterized by significant nerve damage, leading to muscle weakness and atrophy, sensory loss, and in severe cases, disability. Early detection through genetic testing is crucial for managing symptoms, planning treatment strategies, and providing genetic counseling for affected families.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing the genetic material for specific mutations in the NDRG1 gene. The process is highly accurate, providing individuals and healthcare professionals with vital information on the genetic basis of the condition.
The cost of the NDRG1 Gene CMT4D Genetic Test is 4400 AED. While the price may seem significant, the value of obtaining a precise diagnosis cannot be overstated, as it opens the door to targeted interventions and supports better clinical outcomes for patients with this genetic condition.
The "VLDLR Gene Cerebellar Hypoplasia and Mental Retardation with or without Quadrupedal Locomotion Type 1 Genetic Test" is a specialized diagnostic assessment available at DNA Labs UAE, designed to detect mutations in the VLDLR gene. These mutations are associated with a rare genetic disorder characterized by underdevelopment of the cerebellum (cerebellar hypoplasia), intellectual disability, and in some cases, an unusual pattern of movement that may include walking on all fours (quadrupedal locomotion). The test plays a crucial role in confirming the diagnosis, allowing for a better understanding of the condition, and facilitating appropriate management and support strategies for affected individuals and their families. The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify the presence of mutations in the VLDLR gene.
The CST3 Gene Cerebral Amyloid Angiopathy Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the CST3 gene, which are linked to an increased risk of cerebral amyloid angiopathy (CAA). CAA is a neurological condition characterized by the accumulation of amyloid proteins in the walls of the blood vessels in the brain, leading to various complications such as hemorrhagic stroke, dementia, and cognitive decline. The test is particularly crucial for individuals with a family history of CAA or related symptoms, as early detection can significantly aid in managing the condition and tailoring appropriate treatment strategies. Priced at 4400 AED, this genetic test offers a valuable tool for patients and healthcare providers to understand the genetic predisposition to CAA, enabling proactive healthcare measures. DNA Labs UAE, with its state-of-the-art facilities and expert team, ensures accurate and reliable testing outcomes, contributing to the advancement of personalized medicine in the region.
The "APP Gene Cerebral Amyloid Angiopathy APP Related Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the APP gene, which can lead to cerebral amyloid angiopathy (CAA). This condition is characterized by the accumulation of amyloid proteins in the walls of the cerebral arteries, leading to a range of neurological problems, including an increased risk of hemorrhagic stroke. The test is critical for individuals with a family history of CAA or related symptoms, as it can provide essential information for early diagnosis and management of the condition. The cost of the test is 4400 AED, reflecting the comprehensive analysis and expertise required to accurately identify the presence of APP gene mutations.
The PRKCH gene, associated with the protein kinase C eta type, has been linked to an increased susceptibility to cerebral infarction, a type of ischemic stroke where blood flow to a part of the brain is obstructed, leading to brain tissue damage. Given the significant role genetics play in the risk of developing cerebral infarction, genetic testing for variations in the PRKCH gene can provide crucial information for individuals concerned about their stroke risk.
DNA Labs UAE offers a specialized genetic test focused on the PRKCH gene to assess an individual's susceptibility to cerebral infarction. This test is particularly beneficial for those with a family history of stroke or identified risk factors, enabling them to take preventive measures based on their genetic predisposition. The cost of the test is 4400 AED, which reflects the comprehensive analysis and personalized risk assessment provided.
By opting for this test, individuals can gain valuable insights into their genetic makeup, empowering them with the information needed to make informed health decisions. It's a proactive approach to health management, allowing for personalized preventive strategies to reduce the risk of cerebral infarction.
The GAD1 Gene Cerebral Palsy Type 1 Spastic Quadriplegic Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, aimed at identifying genetic mutations associated with Type 1 Spastic Quadriplegic Cerebral Palsy. This condition, a form of cerebral palsy, is characterized by significant muscle stiffness and weakness in all four limbs, affecting an individual's ability to move and maintain balance and posture. The test focuses on mutations in the GAD1 gene, which have been linked to the development of this specific type of cerebral palsy.
Understanding the genetic underpinnings of cerebral palsy can provide crucial insights into the condition's etiology, potentially guiding treatment options and management strategies. This genetic test is priced at 4400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring accuracy and reliability of the results. Through a simple and minimally invasive process, DNA Labs UAE offers individuals and families the opportunity to gain valuable genetic information, paving the way for personalized care plans and interventions.
The KANK1 Gene Cerebral Palsy Type 2 Spastic Quadriplegic Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the KANK1 gene, which have been associated with Type 2 Spastic Quadriplegic Cerebral Palsy. This form of cerebral palsy is characterized by severe motor dysfunction affecting all four limbs, leading to muscle stiffness, reduced mobility, and coordination challenges. The test plays a crucial role in the early diagnosis and management of the condition, allowing for tailored interventions and support to improve the quality of life for affected individuals. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test is priced at 4400 AED, reflecting the sophisticated technology and expertise involved in identifying the genetic underpinnings of this complex neurological disorder.
The CYP27A1 gene cerebrotendinous xanthomatosis genetic test is a specialized diagnostic tool used to identify mutations in the CYP27A1 gene, which are linked to cerebrotendinous xanthomatosis (CTX). CTX is a rare, inherited metabolic disorder characterized by abnormal storage of cholesterol and cholestanol in various tissues of the body, leading to neurological problems, premature atherosclerosis, cataracts, and xanthomas. The test involves analyzing the patient's DNA to detect mutations in the CYP27A1 gene, which is crucial for bile acid synthesis. Early diagnosis through genetic testing is vital for managing symptoms and preventing disease progression through appropriate treatments. This test is available at DNA Labs UAE, a leading facility in genetic diagnostics, at a cost of 4400 AED.
